Dengue vaccines: recent developments, ongoing challenges and current candidates.
about
The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictusAedes aegypti Control Strategies in Brazil: Incorporation of New Technologies to Overcome the Persistence of Dengue EpidemicsTackling dengue fever: Current status and challengesSafety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical TrialsIntroducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendationsHistorical Perspectives on Flavivirus ResearchDengue in children: a systematic review of clinical and laboratory factors associated with severity.Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infectionAn Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in MiceCharacterizing the Conformational Landscape of Flavivirus Fusion Peptides via Simulation and ExperimentConsumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations.Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates?Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Working towards dengue as a vaccine-preventable disease: challenges and opportunities.A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate
P2860
Q22680660-F884FC75-E29C-4BC8-85B9-92BE5192AE11Q24273310-3A756F6E-67D4-4B62-BE8E-5BC511E0AE3FQ24288867-2D8AB9C6-5DAE-4C9F-9A0C-340142C6C564Q26700096-C9CB5043-31F3-4A2A-AEB7-5A89DE14EC2CQ26823330-CD8F1750-7F36-4E44-8E9B-91EC0D4994E8Q29994534-F4F052FB-4477-4227-A77C-074B772DA724Q33427326-BB71F795-C736-4C0F-A83B-D81C45561377Q33959381-73520DD7-3789-469D-BCEF-C47037E13ED1Q35601805-CF6D90E4-CFCF-411E-ABF7-3AAD42182919Q35681101-51F0A598-1BB9-4DC5-ACB6-FCF36264FFAAQ35756190-AF6F7F21-9A44-4790-BF80-6E2978532D68Q35880666-7C4BDD86-9529-4986-9393-5DE2292819EAQ36500499-5EEBE639-FEEC-44BE-841C-4374F256C3FDQ37619957-05B0E941-D0A8-4DB4-B8AC-D0C39C263717Q38618056-46B7A460-EC24-460F-91DC-73915B71BE0AQ38636217-6B6E9295-9EB5-4559-955D-D6E1853B9884Q38657783-FA90C5FC-EEE8-4D2D-ACD5-879D2EE1E130Q42977175-EC48DBB8-CE27-461B-AEB1-0476EFF27BE2Q47562022-B407BD41-ABBC-45DA-8076-24BCF735BE28Q58740569-B5FA69DD-0122-47D8-9092-9FE0454BC471
P2860
Dengue vaccines: recent developments, ongoing challenges and current candidates.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@ast
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@en
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@nl
type
label
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@ast
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@en
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@nl
prefLabel
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@ast
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@en
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@nl
P2093
P2860
P1476
Dengue vaccines: recent developments, ongoing challenges and current candidates.
@en
P2093
Marcelo B Sztein
Monica A McArthur
Robert Edelman
P2860
P304
P356
10.1586/14760584.2013.815412
P577
2013-08-01T00:00:00Z